Delivery Order SPE2DB20D1109-SPE2DB25FP85P
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $45,196.15 by the Defense Logistics Agency on September 25, 2025, with an ultimate completion date of September 26, 2025. The contract covers the supply of Wezlana 90 mg/mL syringes and is structured as a firm fixed price delivery order with no set-aside designation. This award represents a competitive procurement under an existing contract vehicle, demonstrating AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a $16,721.61 delivery order by the Defense Logistics Agency (DLA) for Wezlana 90 mg/ml syringes, with an ultimate completion date of April 22, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a tactical procurement of pharmaceutical supplies to support federal medical supply chain...
- The Defense Logistics Agency awarded a $13,626.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes, with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026. The product will be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $74,758.45 by the Defense Logistics Agency on August 14, 2025, for the supply of Wezlana 90 mg/mL syringes. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 15, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a child delivery order issued under...
- The Defense Logistics Agency awarded a $70,310.56 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Wezlana 90 mg/mL syringes. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is September 4, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $55,296.33 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Wezlana 90 mg/ml syringes. This non-set-aside, firm fixed price contract is scheduled for completion by July 28, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $34,801.18 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $55,988.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Wezlana 90 mg/mL syringes. The contract is non-competitive with no set-aside designation and carries an ultimate completion date of July 17, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's substantially...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes with a ceiling value of $13,396.25 under a firm fixed price contract type. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and the work will be performed in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order that represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for supply of Wezlana 90 mg/ml syringes valued at $30,098.11. This non-set-aside, firm fixed-price delivery order represents a competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP85PDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $138,973.05 by the Defense Logistics Agency for the supply of Wezlana 90 mg/mL syringes. The contract, issued on September 29, 2025, with a completion date of September 30, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of pharmaceutical products and medical supplies to military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's demonstrated capability to meet federal procurement requirements through competitive open competition is evidenced by its consistent receipt of non-set-aside awards across multiple therapeutic domains. This delivery order for Wezlana syringes represents part of the company's ongoing fulfillment of specialized medical commodity needs supporting Department of Defense healthcare programs and the broader military medical supply infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $139.0k | 9/29/25 |